| Basics |
Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet.
|
| IPO Date: |
May 1, 2007 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$107.07M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.22 | 2.98%
|
| Avg Daily Range (30 D): |
$0.06 | 2.57%
|
| Avg Daily Range (90 D): |
$0.05 | 2.25%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.25M |
| Avg Daily Volume (30 D): |
.19M |
| Avg Daily Volume (90 D): |
.12M |
| Trade Size |
| Avg Trade Size (Sh.): |
158 |
| Avg Trade Size (Sh.) (30 D): |
224 |
| Avg Trade Size (Sh.) (90 D): |
248 |
| Institutional Trades |
| Total Inst.Trades: |
114 |
| Avg Inst. Trade: |
$1.66M |
| Avg Inst. Trade (30 D): |
$1.25M |
| Avg Inst. Trade (90 D): |
$1.25M |
| Avg Inst. Trade Volume: |
.17M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.39M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
297.23K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$1.16
|
$.32
|
$-.19
|
|
Diluted EPS
|
$1.13
|
$.31
|
$-.19
|
|
Revenue
|
$ M
|
$ M
|
$ 2M
|
|
Gross Profit
|
$ M
|
$ M
|
$ .01M
|
|
Net Income / Loss
|
$ 48.39M
|
$ 13.26M
|
$ -7.64M
|
|
Operating Income / Loss
|
$ -2.43M
|
$ -2.49M
|
$ -4.5M
|
|
Cost of Revenue
|
$ M
|
$ M
|
$ 1.99M
|
|
Net Cash Flow
|
$ 36.38M
|
$ -38.62M
|
$ M
|
|
PE Ratio
|
2.41
|
|
|
| Splits |
|
Jan 23, 2013:
1:12
|
|
|
|
